Trial record 1 of 1 for:
17-BI-1206-02
A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03571568 |
|
Recruitment Status :
Recruiting
First Posted : June 27, 2018
Last Update Posted : January 30, 2024
|
Sponsor:
BioInvent International AB
Information provided by (Responsible Party):
BioInvent International AB
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 22, 2025 |
| Estimated Study Completion Date : | September 22, 2025 |